Title : Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients.

Pub. Date : 2022

PMID : 35197967






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Results: RRMS patients during fingolimod (FTY) and natalizumab (NTZ) treatment showed increased percentage of circulating CD8+GzmB+ T lymphocytes when compared to healthy volunteers. Fingolimod Hydrochloride CD8a molecule Homo sapiens